SYSTEMATIC REVIEW
Accepted on 15 Apr 2025
Immunogenicity Risk Assessment for Tailored Mitigation and Monitoring of Biotherapeutics During Development: Recommendations from the European Immunogenicity Platform
doi 10.3389/fimmu.2025.1581153
- 323 views
- Frontiers in Immunology
- Vaccines and Molecular Therapeutics
- Research Topics
- Advances in Immunogenicity Risk Assessment, Monitoring and Mitigation of Biologics
Advances in Immunogenicity Risk Assessment, Monitoring and Mitigation of Biologics
1,469
Total downloads
7,180
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 20 Mar 2025
The first WHO reference panel for Infliximab anti-drug antibodies: a step towards harmonizing therapeutic drug monitoring
doi 10.3389/fimmu.2025.1550655
- 675 views
ORIGINAL RESEARCH
Published on 27 Feb 2025
Antidrug antibodies to adalimumab do not associate with immunologically related adverse events
doi 10.3389/fimmu.2024.1457993
- 1,189 views
ORIGINAL RESEARCH
Published on 13 Feb 2025
A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity
doi 10.3389/fimmu.2025.1519452
- 1,213 views
ORIGINAL RESEARCH
Published on 10 Dec 2024
Immune regulatory adjuvant approach to mitigate subcutaneous immunogenicity of monoclonal antibodies
doi 10.3389/fimmu.2024.1496169
- 1,279 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.